Kat6-IN-1
2-methoxy-N-[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]benzenesulfonamide
Molecular Identity
Kat6-IN-1
2-methoxy-N-[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]benzenesulfonamide
PubChem CID: 155411211
2D Structure
Properties
C19H18N4O5S
Molecular Formula
414.40
Molecular Weight
g/mol
414.0998
Exact Mass
Da
2.4
XLogP
Drug-like (Lipinski: < 5)
117
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
8
H-Bond Acceptors
645
Complexity
SMILES
Canonical SMILES
SMILES: COC1=CC=CC=C1S(=O)(=O)NC2=NOC3=C2C(=CC(=C3)CN4C=CC=N4)OCIsomeric SMILES
SMILES: COC1=CC=CC=C1S(=O)(=O)NC2=NOC3=C2C(=CC(=C3)CN4C=CC=N4)OCSynonyms(20)
KAT6-IN-12569008-99-5PrifetrastatN-(6-((1H-Pyrazol-1-yl)methyl)-4-methoxybenzo[d]isoxazol-3-yl)-2-methoxybenzenesulfonamidePF-07248144Prifetrastat (USAN)PRIFETRASTAT [USAN]2-methoxy-N-[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]benzenesulfonamideprifetrastat [INN]Prifetrastat [WHO-DD]GN6DU4ZE30orb1982278CHEMBL6068620SCHEMBL22802427SCHEMBL29490368
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Kat6-IN-1
Loading drug network...